Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06267300
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-02-19
Brief Title:
Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy a Randomized Controlled Trial
Sponsor:
Erasmus Medical Center
Organization:
Erasmus Medical Center
Study Overview
Official Title:
Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy a Randomized Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical try is to investigate the effect of hyperbaric oxygen therapy HBOT on symptoms quality of life and absence of work through sickness in patients with post-COVID on short- and mid-term as well as to identify biochemical mechanisms of action
The main questions it aims to answer are
What is the clinical relevance of improvements of symptoms and quality of life after treatment with HBOT for post-COVID
What are the changes in absence from work after treatment with HBOT
What is the cost-effectiveness of treatment with HBOT
What are possible mechanisms of action of HBOT
Participants will undergo 40 sessions of HBOT Researchers will compare HBOT with standard care alone control group In case of a positive outcome patients in the control group can cross-over to the HBOT group after 6 months
The main questions it aims to answer are
What is the clinical relevance of improvements of symptoms and quality of life after treatment with HBOT for post-COVID
What are the changes in absence from work after treatment with HBOT
What is the cost-effectiveness of treatment with HBOT
What are possible mechanisms of action of HBOT
Participants will undergo 40 sessions of HBOT Researchers will compare HBOT with standard care alone control group In case of a positive outcome patients in the control group can cross-over to the HBOT group after 6 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None